PubMed:23267857
Annnotations
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-81 | Sentence | denotes | CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. |
| T2 | 82-331 | Sentence | denotes | Single-nucleotide polymorphisms (SNPs) in the CYP2C gene cluster have been extensively investigated as predisposing factors for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcer disease (PUD) or upper gastrointestinal bleeding (UGIB). |
| T3 | 332-460 | Sentence | denotes | However, results have been inconclusive owing to different study designs, limited genotyping strategies, and small sample sizes. |
| T4 | 461-695 | Sentence | denotes | We investigated whether eight functional SNPs in the CYP2C family of genes--CYP2C8*3 (rs11572080 and rs10509681), CYP2C8*4, CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, and CYP2C19*17--are associated with PUD in 1,239 Caucasian patients. |
| T5 | 696-804 | Sentence | denotes | Logistic regression analysis showed that only CYP2C19*17 was associated with PUD (odds ratio additive model: |
| T6 | 805-949 | Sentence | denotes | 1.47 (95% confidence interval (CI) 1.12 to 1.92); P = 0.005; R(2) 16%), but not UGIB, independent of NSAID use or Helicobacter pylori infection. |
| T7 | 950-1085 | Sentence | denotes | PUD distribution varied (P = 0.024) according to CYP2C19*17 genotype: *1/*1, 490 (64.3%); *1/*17, 304 (71.7%); and *17/*17, 31 (73.8%). |
| T8 | 1086-1179 | Sentence | denotes | CYP2C19*17, a gain-of-function polymorphism, is associated with PUD irrespective of etiology. |
| T1 | 0-81 | Sentence | denotes | CYP2C19*17 gain-of-function polymorphism is associated with peptic ulcer disease. |
| T2 | 82-331 | Sentence | denotes | Single-nucleotide polymorphisms (SNPs) in the CYP2C gene cluster have been extensively investigated as predisposing factors for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcer disease (PUD) or upper gastrointestinal bleeding (UGIB). |
| T3 | 332-460 | Sentence | denotes | However, results have been inconclusive owing to different study designs, limited genotyping strategies, and small sample sizes. |
| T4 | 461-695 | Sentence | denotes | We investigated whether eight functional SNPs in the CYP2C family of genes--CYP2C8*3 (rs11572080 and rs10509681), CYP2C8*4, CYP2C9*2, CYP2C9*3, CYP2C19*2, CYP2C19*3, and CYP2C19*17--are associated with PUD in 1,239 Caucasian patients. |
| T5 | 696-804 | Sentence | denotes | Logistic regression analysis showed that only CYP2C19*17 was associated with PUD (odds ratio additive model: |
| T6 | 805-949 | Sentence | denotes | 1.47 (95% confidence interval (CI) 1.12 to 1.92); P = 0.005; R(2) 16%), but not UGIB, independent of NSAID use or Helicobacter pylori infection. |
| T7 | 950-1085 | Sentence | denotes | PUD distribution varied (P = 0.024) according to CYP2C19*17 genotype: *1/*1, 490 (64.3%); *1/*17, 304 (71.7%); and *17/*17, 31 (73.8%). |
| T8 | 1086-1179 | Sentence | denotes | CYP2C19*17, a gain-of-function polymorphism, is associated with PUD irrespective of etiology. |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 0-7 | gene:1557 | denotes | CYP2C19 |
| T1 | 60-80 | disease:C0030920 | denotes | peptic ulcer disease |
| T2 | 128-133 | gene:1559 | denotes | CYP2C |
| T3 | 284-287 | disease:C0030920 | denotes | PUD |
| T4 | 128-133 | gene:1557 | denotes | CYP2C |
| T5 | 262-282 | disease:C0030920 | denotes | peptic ulcer disease |
| T6 | 128-133 | gene:1562 | denotes | CYP2C |
| T7 | 262-282 | disease:C0030920 | denotes | peptic ulcer disease |
| T8 | 128-133 | gene:1562 | denotes | CYP2C |
| T9 | 284-287 | disease:C0030920 | denotes | PUD |
| T10 | 128-133 | gene:1559 | denotes | CYP2C |
| T11 | 262-282 | disease:C0030920 | denotes | peptic ulcer disease |
| T12 | 128-133 | gene:1557 | denotes | CYP2C |
| T13 | 284-287 | disease:C0030920 | denotes | PUD |
| T14 | 742-749 | gene:1557 | denotes | CYP2C19 |
| T15 | 773-776 | disease:C0030920 | denotes | PUD |
| T16 | 742-749 | gene:1557 | denotes | CYP2C19 |
| T17 | 919-948 | disease:C0850666 | denotes | Helicobacter pylori infection |
| T18 | 1086-1093 | gene:1557 | denotes | CYP2C19 |
| T19 | 1150-1153 | disease:C0030920 | denotes | PUD |
| R1 | T0 | T1 | associated_with | CYP2C19,peptic ulcer disease |
| R2 | T2 | T3 | associated_with | CYP2C,PUD |
| R3 | T4 | T5 | associated_with | CYP2C,peptic ulcer disease |
| R4 | T6 | T7 | associated_with | CYP2C,peptic ulcer disease |
| R5 | T8 | T9 | associated_with | CYP2C,PUD |
| R6 | T10 | T11 | associated_with | CYP2C,peptic ulcer disease |
| R7 | T12 | T13 | associated_with | CYP2C,PUD |
| R8 | T14 | T15 | associated_with | CYP2C19,PUD |
| R9 | T16 | T17 | associated_with | CYP2C19,Helicobacter pylori infection |
| R10 | T18 | T19 | associated_with | CYP2C19,PUD |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_23267857_1_0 | 82-113 | expanded | denotes | Single-nucleotide polymorphisms |
| SS2_23267857_1_0 | 115-119 | abbr | denotes | SNPs |
| SS1_23267857_1_1 | 210-245 | expanded | denotes | nonsteroidal anti-inflammatory drug |
| SS2_23267857_1_1 | 247-252 | abbr | denotes | NSAID |
| SS1_23267857_1_2 | 262-282 | expanded | denotes | peptic ulcer disease |
| SS2_23267857_1_2 | 284-287 | abbr | denotes | PUD |
| SS1_23267857_1_3 | 292-323 | expanded | denotes | upper gastrointestinal bleeding |
| SS2_23267857_1_3 | 325-329 | abbr | denotes | UGIB |
| SS1_23267857_4_0 | 815-834 | expanded | denotes | confidence interval |
| SS2_23267857_4_0 | 836-838 | abbr | denotes | CI |
| AE1_23267857_1_0 | SS1_23267857_1_0 | SS2_23267857_1_0 | abbreviatedTo | Single-nucleotide polymorphisms,SNPs |
| AE1_23267857_1_1 | SS1_23267857_1_1 | SS2_23267857_1_1 | abbreviatedTo | nonsteroidal anti-inflammatory drug,NSAID |
| AE1_23267857_1_2 | SS1_23267857_1_2 | SS2_23267857_1_2 | abbreviatedTo | peptic ulcer disease,PUD |
| AE1_23267857_1_3 | SS1_23267857_1_3 | SS2_23267857_1_3 | abbreviatedTo | upper gastrointestinal bleeding,UGIB |
| AE1_23267857_4_0 | SS1_23267857_4_0 | SS2_23267857_4_0 | abbreviatedTo | confidence interval,CI |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 262-274 | HP_0004398 | denotes | peptic ulcer |
| T2 | 298-323 | HP_0002239 | denotes | gastrointestinal bleeding |
| T3 | 919-948 | HP_0005202 | denotes | Helicobacter pylori infection |
DisGeNET5_variant_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 23267857-3#86#96#geners11572080 | 547-557 | geners11572080 | denotes | rs11572080 |
| 23267857-3#101#111#geners10509681 | 562-572 | geners10509681 | denotes | rs10509681 |
| 23267857-3#202#205#diseaseC0030920 | 663-666 | diseaseC0030920 | denotes | PUD |
| 86#96#geners11572080202#205#diseaseC0030920 | 23267857-3#86#96#geners11572080 | 23267857-3#202#205#diseaseC0030920 | associated_with | rs11572080,PUD |
| 101#111#geners10509681202#205#diseaseC0030920 | 23267857-3#101#111#geners10509681 | 23267857-3#202#205#diseaseC0030920 | associated_with | rs10509681,PUD |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 23267857-0#0#7#gene1557 | 0-7 | gene1557 | denotes | CYP2C19 |
| 23267857-0#60#80#diseaseC0030920 | 60-80 | diseaseC0030920 | denotes | peptic ulcer disease |
| 23267857-3#53#58#gene1559 | 514-519 | gene1559 | denotes | CYP2C |
| 23267857-3#53#58#gene1562 | 514-519 | gene1562 | denotes | CYP2C |
| 23267857-3#76#82#gene1558 | 537-543 | gene1558 | denotes | CYP2C8 |
| 23267857-3#114#120#gene1558 | 575-581 | gene1558 | denotes | CYP2C8 |
| 23267857-3#202#205#diseaseC0030920 | 663-666 | diseaseC0030920 | denotes | PUD |
| 23267857-3#202#205#diseaseC0030920 | 663-666 | diseaseC0030920 | denotes | PUD |
| 23267857-4#46#53#gene1557 | 742-749 | gene1557 | denotes | CYP2C19 |
| 23267857-4#223#252#diseaseC0850666 | 919-948 | diseaseC0850666 | denotes | Helicobacter pylori infection |
| 0#7#gene155760#80#diseaseC0030920 | 23267857-0#0#7#gene1557 | 23267857-0#60#80#diseaseC0030920 | associated_with | CYP2C19,peptic ulcer disease |
| 53#58#gene1559202#205#diseaseC0030920 | 23267857-3#53#58#gene1559 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C,PUD |
| 53#58#gene1559202#205#diseaseC0030920 | 23267857-3#53#58#gene1559 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C,PUD |
| 53#58#gene1562202#205#diseaseC0030920 | 23267857-3#53#58#gene1562 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C,PUD |
| 53#58#gene1562202#205#diseaseC0030920 | 23267857-3#53#58#gene1562 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C,PUD |
| 76#82#gene1558202#205#diseaseC0030920 | 23267857-3#76#82#gene1558 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C8,PUD |
| 76#82#gene1558202#205#diseaseC0030920 | 23267857-3#76#82#gene1558 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C8,PUD |
| 114#120#gene1558202#205#diseaseC0030920 | 23267857-3#114#120#gene1558 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C8,PUD |
| 114#120#gene1558202#205#diseaseC0030920 | 23267857-3#114#120#gene1558 | 23267857-3#202#205#diseaseC0030920 | associated_with | CYP2C8,PUD |
| 46#53#gene1557223#252#diseaseC0850666 | 23267857-4#46#53#gene1557 | 23267857-4#223#252#diseaseC0850666 | associated_with | CYP2C19,Helicobacter pylori infection |
PubTator4TogoVar
| Id | Subject | Object | Predicate | Lexical cue | resolved_to |
|---|---|---|---|---|---|
| 36 | 547-557 | SNP | denotes | rs11572080 | tmVar:rs11572080;VariantGroup:0;CorrespondingGene:1558;RS#:11572080;CorrespondingSpecies:9606 |
| 37 | 562-572 | SNP | denotes | rs10509681 | tmVar:rs10509681;VariantGroup:1;CorrespondingGene:1558;RS#:10509681;CorrespondingSpecies:9606 |
PubTatorOnTogoVar
| Id | Subject | Object | Predicate | Lexical cue | resolved_to |
|---|---|---|---|---|---|
| 36 | 547-557 | SNP | denotes | rs11572080 | tmVar:rs11572080;VariantGroup:0;CorrespondingGene:1558;RS#:11572080;CorrespondingSpecies:9606 |
| 37 | 562-572 | SNP | denotes | rs10509681 | tmVar:rs10509681;VariantGroup:1;CorrespondingGene:1558;RS#:10509681;CorrespondingSpecies:9606 |
| T1 | 547-557 | SNP | denotes | rs11572080 | tmVar:rs11572080;VariantGroup:0;CorrespondingGene:1558;RS#:11572080;CorrespondingSpecies:9606 |
| T2 | 562-572 | SNP | denotes | rs10509681 | tmVar:rs10509681;VariantGroup:1;CorrespondingGene:1558;RS#:10509681;CorrespondingSpecies:9606 |